| pubmed-article:15763336 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15763336 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:15763336 | lifeskim:mentions | umls-concept:C0003272 | lld:lifeskim |
| pubmed-article:15763336 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:15763336 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:15763336 | lifeskim:mentions | umls-concept:C2737043 | lld:lifeskim |
| pubmed-article:15763336 | lifeskim:mentions | umls-concept:C0086597 | lld:lifeskim |
| pubmed-article:15763336 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15763336 | pubmed:dateCreated | 2005-3-14 | lld:pubmed |
| pubmed-article:15763336 | pubmed:abstractText | The role of antibody dependent cellular cytotoxicity (ADCC) in HCV infection is unclear at present. Antibodies mediating ADCC are usually directed against viral envelope proteins. As cell surface expression of the HCV envelope E2 protein has been shown, the HCV E2 protein is an especially promising candidate target for ADCC. | lld:pubmed |
| pubmed-article:15763336 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15763336 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15763336 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15763336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15763336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15763336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15763336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15763336 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15763336 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:15763336 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:SauerbruchTil... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:MatzBertfried... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:SpenglerUlric... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:BrackmannHans... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:LeifeldLudger... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:HoughtonMicha... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:InchauspéGene... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:NattermannJac... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:LanghansBetti... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:SchneidersAng... | lld:pubmed |
| pubmed-article:15763336 | pubmed:author | pubmed-author:SchulzMonikaM | lld:pubmed |
| pubmed-article:15763336 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15763336 | pubmed:volume | 42 | lld:pubmed |
| pubmed-article:15763336 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15763336 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15763336 | pubmed:pagination | 499-504 | lld:pubmed |
| pubmed-article:15763336 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:meshHeading | pubmed-meshheading:15763336... | lld:pubmed |
| pubmed-article:15763336 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15763336 | pubmed:articleTitle | Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). | lld:pubmed |
| pubmed-article:15763336 | pubmed:affiliation | Department of General Internal Medicine I, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. jacob.nattermann@ukb.uni-bonn.de | lld:pubmed |
| pubmed-article:15763336 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15763336 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15763336 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15763336 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15763336 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15763336 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15763336 | lld:pubmed |
